Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire ...

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation ...

If you’re into spy series, this addictive Danish production will likely be right up your alley. The Asset has been making ...

TORONTO — Canada Pension Plan Investment Board says it earned a net return of 5.4 per cent for its second quarter.

Michael Burry, the investor whose successful bets against the U.S. housing market in 2008 were recounted in the movie "The ...